breast cancer
People whose work centres on breast cancer. 20 records carry it: 20 people.
Related tags
20 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Anna Sapino Scientific Director · Istituto di Candiolo IRCCS (FPO) Pathologist and Scientific Director of the Candiolo Cancer Institute (INOC), Piedmont's oncology IRCCS and an OECI-certified Comprehensive Cancer Centre. | HR-positive / HER2-negative breast cancer, HER2-positive breast cancer | none | leadership, clinician-scientist, pathology | ||
Christian Singer Vice-President · Austrian Breast & Colorectal Cancer Study Group Gynaecological oncologist at the Medical University of Vienna and ABCSG Vice-President, known for work on breast cancer and hereditary cancer risk. | HR-positive / HER2-negative breast cancer, Ovarian cancer | none | leadership, clinician-scientist, hereditary cancer | ||
Donna McKay President & CEO · Breast Cancer Research Foundation President and CEO of the Breast Cancer Research Foundation, the largest private funder of breast cancer research worldwide. | HR-positive / HER2-negative breast cancer, HER2-positive breast cancer, Triple-negative breast cancer | none | leadership, research funding | ||
Dorraya El-Ashry Chief Scientific Officer · Breast Cancer Research Foundation Breast cancer biologist and Chief Scientific Officer of the Breast Cancer Research Foundation, directing its global research grant portfolio. | HR-positive / HER2-negative breast cancer, Triple-negative breast cancer | none | leadership, clinician-scientist | ||
Eva Ciruelos Vice President (Vicepresidenta) · SOLTI Cancer Research Group Madrid breast oncologist and Vice President of the SOLTI breast cancer research group. | HR-positive / HER2-negative breast cancer, HER2-positive breast cancer | none | leadership, clinician-scientist | ||
Giovanni Blandino Scientific Director, IRCCS Regina Elena National Cancer Institute · IRCCS Regina Elena National Cancer Institute Molecular oncologist known for mutant p53 research, appointed Scientific Director of Rome's Regina Elena National Cancer Institute in 2026. | Triple-negative breast cancer, Head and neck squamous cell carcinoma | none | leadership, clinician-scientist, molecular oncology | ||
Isabel T. Rubio Past-President · European Society of Surgical Oncology Breast surgeon and ESSO Past-President who heads breast surgical oncology at Clínica Universidad de Navarra in Madrid. | HR-positive / HER2-negative breast cancer, HER2-positive breast cancer, Triple-negative breast cancer | none | leadership, clinician-scientist, surgical oncology | ||
Jason Carroll Interim Director · Cancer Research UK Cambridge Centre / CRUK Cambridge Institute Molecular oncologist and Interim Director of the Cancer Research UK Cambridge Institute, known for mapping how the oestrogen receptor drives breast cancer. | HR-positive / HER2-negative breast cancer | none | leadership, clinician-scientist, basic science | ||
Mafalda Oliveira President (Presidenta) · SOLTI Cancer Research Group Barcelona breast oncologist who leads SOLTI, the Spanish academic breast cancer research group, and co-authors pivotal endocrine therapy trials. | HR-positive / HER2-negative breast cancer | none | leadership, clinician-scientist, clinical trials | ||
Marek Svoboda General Director · Masaryk Memorial Cancer Institute Medical oncologist who leads the Masaryk Memorial Cancer Institute in Brno, the Czech Republic's largest dedicated cancer centre. | HR-positive / HER2-negative breast cancer, HER2-positive breast cancer | none | leadership, clinician-scientist, medical oncology | ||
Michael Gnant President · Austrian Breast & Colorectal Cancer Study Group Viennese surgical oncologist who presides over the ABCSG and has led landmark adjuvant breast cancer trials such as ABCSG-12, ABCSG-18 and PALLAS. | HR-positive / HER2-negative breast cancer, HER2-positive breast cancer | none | leadership, clinician-scientist, clinical trials | ||
Nikolaus Rajewsky Group Leader, Systems Biology of Gene Regulatory Elements; Scientific Director, Berlin Institute for Medical Systems Biology (MDC-BIMSB) · Max Delbrück Center for Molecular Medicine Systems biologist at the MDC known for microRNA and circular RNA discoveries and for single-cell and spatial genomics applied to cancer. | Triple-negative breast cancer, Non-small-cell lung cancer, Neuroblastoma | none | clinician-scientist, systems biology, genomics | ||
Norman Wolmark Chairman · NSABP Foundation Surgical oncologist and long-time Chairman of the NSABP, whose trials established breast-conserving surgery and adjuvant therapy standards in breast and colorectal cancer. | HR-positive / HER2-negative breast cancer, HER2-positive breast cancer, Colorectal cancer | none | leadership, clinician-scientist, clinical trials | ||
Priya Rastogi Chief Executive Officer & Medical Director · NSABP Foundation Pittsburgh medical oncologist who serves as CEO and Medical Director of the NSABP Foundation, leading its breast cancer trial portfolio. | HR-positive / HER2-negative breast cancer, HER2-positive breast cancer, Triple-negative breast cancer | none | leadership, clinician-scientist, clinical trials | ||
Rebecca Dent Deputy Chief Executive Officer (Clinical) · National Cancer Centre Singapore Breast medical oncologist and Deputy CEO for clinical operations at the National Cancer Centre Singapore, an international leader in triple-negative breast cancer trials. | Triple-negative breast cancer, HR-positive / HER2-negative breast cancer, HER2-positive breast cancer | none | leadership, clinician-scientist | ||
Sara Y. Brucker Deputy Speaker; Medical Director, Department for Women's Health · Comprehensive Cancer Center Tübingen-Stuttgart Gynaecologist who co-leads the CCC Tübingen-Stuttgart and directs women's health at Tübingen University Hospital, with research in breast and gynaecological cancers. | HR-positive / HER2-negative breast cancer, Endometrial cancer, Ovarian cancer | none | leadership, clinician-scientist, gynaecological oncology | ||
Sunil Lakhani Chair of the Board · Breast Cancer Trials Brisbane breast pathologist who chairs the board of Breast Cancer Trials, the Australia and New Zealand breast cancer clinical trials group. | HR-positive / HER2-negative breast cancer, HER2-positive breast cancer, Triple-negative breast cancer | none | leadership, clinician-scientist, pathology | ||
Susan Clark Head of the Cancer Epigenetics Laboratory · Garvan Institute of Medical Research / Kinghorn Cancer Centre Pioneer of DNA methylation analysis whose Garvan laboratory studies how epigenetic changes drive prostate and breast cancer. | Prostate cancer, HR-positive / HER2-negative breast cancer | none | clinician-scientist, epigenetics, prostate cancer | ||
Suzette Delaloge Chair of the Board of Directors · Institut National du Cancer Breast medical oncologist from Gustave Roussy who chairs the board of France's Institut National du Cancer. | HR-positive / HER2-negative breast cancer, HER2-positive breast cancer, Triple-negative breast cancer | none | leadership, clinician-scientist, cancer policy | ||
Tari A. King President-Elect · Society of Surgical Oncology Breast surgical oncologist at Winship Cancer Institute and President-Elect of the Society of Surgical Oncology, known for research on lobular breast cancer and surgical de-escalation. | HR-positive / HER2-negative breast cancer, HER2-positive breast cancer | none | leadership, clinician-scientist, surgical oncology |
